Ziva DRA supports pharmaceutical companies with planning, coordination, documentation and regulatory support for bioavailability and bioequivalence study programs connected with product development and registration.
Bioavailability and bioequivalence studies can be important elements of pharmaceutical development and regulatory programs. Their design and execution require close coordination between clinical, analytical and regulatory workstreams.
Ziva DRA helps clients review the development objective, define the expected support scope, organize study documentation and coordinate relevant clinical and bioanalytical activities.
BA/BE studies can also connect with medicine registration, dossier preparation, bioanalytics and broader clinical research support depending on the product-development strategy.
The final project scope depends on the product, study design and regulatory objective. Support may include the following workstreams.
Review product characteristics, development objective and anticipated study requirements.
Help structure the clinical, analytical and regulatory components of the study program.
Support review and organization of relevant protocol and study documentation.
Support coordination of relevant clinical study activities and project workstreams.
Coordinate analytical requirements and related bioanalytical study activities.
Support organization of study outputs and relevant regulatory documentation.
BA/BE programs require structured coordination across planning, clinical execution, bioanalysis and regulatory documentation.
Understand formulation and development objective.
Define the likely clinical and analytical scope.
Coordinate relevant clinical-study activities.
Coordinate relevant analytical workstreams.
Organize relevant results and regulatory documentation.
Study-specific documentation and development information should be reviewed before the project begins.
A clear product-development profile helps define the appropriate BA/BE study strategy.
Exact study requirements depend on the product and applicable development pathway.
BA/BE studies sit at the intersection of clinical research, bioanalytics and regulatory development.
Align the study with the pharmaceutical development and registration objective.
Keep study execution connected with the broader project timeline.
Coordinate analytical requirements with clinical-study activities.
Connect study outputs to the relevant regulatory and dossier workstream.
Companies requiring BA/BE support as part of pharmaceutical development programs.
Manufacturers developing products for registration and market entry.
Overseas companies requiring coordinated research support in Bangladesh.
Teams coordinating clinical evidence, bioanalytics and registration dossiers.
Yes. Ziva DRA can support international sponsors and pharmaceutical companies requiring Bangladesh-focused BA/BE study coordination.
No. Study requirements vary according to the product, formulation, development objective and applicable regulatory pathway.
Yes. Clinical and bioanalytical workstreams can be coordinated as part of the broader BA/BE project.
Yes. BA/BE studies, bioanalytics, dossier preparation and medicine registration can form connected workstreams within the same development program.
Share your product profile, formulation, development objective and available study information with Ziva DRA so the appropriate clinical, bioanalytical and regulatory scope can be assessed.